文献速递血液净化与透析

终末期肾病临床试验:优先事项与挑战

Clinical trials in end-stage renal disease-priorities and challenges.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

终末期肾病患者并发症和死亡率极高,除透析外,经 properly 设计的随机对照试验(RCT)证实的治疗干预几乎不存在。历史上该人群RCT数量远低于其他医学专科,且少数大型RCT结果不确定或阴性,削弱了投资热情。近期以患者为中心结局和患者参与试验规划与实施的倡议,可能促成更贴近临床的RCT和更广泛的代表性参与;采用实用临床试验和平台试验的新型设计要素,可提高内部和外部有效性,加速治疗干预向临床实践转化。

要点

  • 终末期肾病患者除透析外,缺乏经RCT证实的改善结局的干预措施。
  • 历史上该人群RCT数量远低于其他专科,少数大型RCT结果不确定或阴性。
  • 以患者为中心结局和新型试验设计可提高RCT相关性和代表性。

核心结论

  • 终末期肾病领域亟需更多以患者为中心、设计良好的随机对照试验来验证治疗干预。
  • 采用实用临床试验和平台试验设计要素可提高RCT的内部和外部有效性。
  • 促进患者和照护者参与试验规划与实施,有望产生更贴近临床的RCT和更广泛的代表性参与。

研究设计与样本

  • 本文为综述,讨论终末期肾病临床试验的优先事项与挑战。

主要发现

  • 终末期肾病患者并发症和死亡率极高,除透析外几乎没有经 properly 设计的RCT证实的治疗干预。
  • 历史上终末期肾病RCT数量远低于其他医学专科。
  • 少数大型RCT结果不确定或阴性,削弱了未来类似试验的投资热情。

临床怎么用

  • 临床应关注以患者为中心结局的试验设计,并鼓励患者参与试验规划。
  • 可借鉴实用临床试验和平台试验设计要素,提高试验的临床转化效率。

局限性

  • 本文为综述,未提供原始研究数据或定量分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with end-stage renal disease (ESRD) experience extremely high morbidity and mortality and there are virtually no therapeutic interventions besides dialysis treatment that are proven in properly designed randomized controlled trials (RCTs) to improve patients' outcomes. Historically, the number of RCTs performed in the ESRD population has been very low compared with other medical subspecialties, and several of the few large RCTs have yielded inconclusive or negative results, dampening enthusiasm for future investment in similar trials. Recent initiatives promoting a focus on patient-centered outcomes and more active patient and caregiver involvement in the planning and conduct of clinical trials may result in more clinically relevant RCTs and broader participation from patients representing the diversity of the ESRD population. The adoption of novel clinical trial design elements characteristic of pragmatic clinical trials and platform trials could help improve both the internal and external validity of RCTs in ESRD, ultimately resulting in the adoption of therapeutic interventions that can be rapidly translated to clinical practice.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Kovesdy CP. Clinical trials in end-stage renal disease-priorities and challenges. Nephrol Dial Transplant. 2019. PMID: 31190058. doi:10.1093/ndt/gfz088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。